Skip to content

The comparison of Negative pressure wound therapy (NPWT) and conventional moist dressings in the wound bed preparation for diabetic foot ulcers

The comparison of Negative pressure wound therapy (NPWT) and conventional moist dressings in the wound bed preparation for diabetic foot ulcers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059940
Enrollment
Unknown
Registered
2022-05-14
Start date
2022-09-01
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic foot ulcers

Interventions

0:VAC(vacuum-assisted closure)
1:control group (conventional moist dressings alginates)

Sponsors

Nanjing First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with diabetes foot ulcer who meet the diagnostic criteria; 2. The age is between 20 and 80 years old; 3. diabetes foot ulcer, Wagner's grade is 2-3, and the course of disease is more than 2 weeks; 4. Ankle-brachial index (ABI) is 0.5-0.9; 5. The wound area of diabetes foot ulcer is 8-20cm2.

Exclusion criteria

Exclusion criteria: 1. Unable to cooperate to complete the follow-up; 2. Pregnant and lactating women; 3. Foot ulcer caused by other reasons (non diabetes); 4. Organ failure (heart failure, respiratory failure, liver failure, renal damage or intestinal failure); Patients with malignant tumors and hematological diseases; 5. Patients with peripheral vascular diseases or autoimmune diseases (rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus, Sjogren's syndrome, connective tissue disease, systemic vasculitis); 6. Patients who have received local growth factor therapy or hyperbaric oxygen therapy in the past month; 7. Complicated with serious medical diseases, or used corticosteroids, immunosuppressants or chemotherapy drugs in the past 6 months; 8. Other conditions that the researcher thinks are not suitable for enrollment.

Design outcomes

Primary

MeasureTime frame
time from first debridement to STSG surgery ;

Secondary

MeasureTime frame
survival rates of skin graf;wound blood perfusion;Neutrophil extracellular traps;wound macrophages;

Countries

China

Contacts

Public ContactWu Yin

Nanjing First Hospital

medwuyin@163.com+86 183 0515 5832

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026